Satellos is a biotech firm established on innovative scientific research focused on the regeneration of skeletal muscles. The company's overarching goal is to develop and progress medications that utilize the body's innate ability for self-restoration, offering a fresh approach to treating severe muscle ailments. Through the use of their exclusive MyoReGenX™ exploration platform, Satellos has revealed substantial understandings into the control of muscle cells. Their findings span a range of conditions, from genetic disorders such as Duchenne muscular dystrophy to age-related disabilities.
Satellos Bioscience
Headquarters
Canada